Supernus Pharmaceuticals: Q3 Earnings Insights - Supernus Pharmaceuticals (NASDAQ:SUPN)

Supernus Pharmaceuticals SUPN reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Supernus Pharmaceuticals missed estimated earnings by 323.08%, reporting an EPS of $-0.29 versus an estimate of $0.13.

Revenue was down $23.47 million from the same period last year.

Last quarter the company beat on EPS by $0.21 which was followed by a 7.23% drop in the share price the next day.

Here's a look at Supernus Pharmaceuticals's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.23	0.17	0.68	0.36
EPS Actual	-0.02	0.29	0.43	0.03
Revenue Estimate	144.38M	139.02M	180.37M	172.48M
Revenue Actual	135.56M	153.76M	167.33M	177.35M

To track all earnings releases for Supernus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.